UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in RARE — Ultragenyx Pharmaceutical Inc.
CIK 861177
NEW YORK, NY
Position in RARE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,583,673
+$910,822 QoQ
Shares Held
167,226
-25.0% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 39%
Shared 0%
None 61%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. RARE ranks #58 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in RARE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,583,673 | 167,226 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,672,851 | 223,048 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $4,694,461 | 204,107 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,227,818 | 207,042 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,942,974 | 300,962 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,413,751 | 232,360 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $8,513,954 | 202,376 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,874,344 | 177,756 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,266,846 | 176,809 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,081,836 | 130,260 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,652,608 | 118,206 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,082,672 | 114,521 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,888,255 | 105,967 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,249,274 | 105,967 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,648,504 | 121,919 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,084,555 | 98,637 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,841,566 | 114,676 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,364,587 | 115,183 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,704,490 | 103,514 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,361,781 | 92,713 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,084,086 | 95,271 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,256,783 | 72,517 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $9,468,747 | 68,401 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $5,369,881 | 65,335 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,700,863 | 60,098 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,683,924 | 60,408 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||